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Abstract
Summary This study was undertaken to investigate the
radiologic and clinical outcomes of vertebroplasty with
calcium phosphate (CaP) cement in patients with osteopo-
rotic vertebral compression fractures. The morphological
changes of injected CaP cement in osteoporotic compressed
vertebral bodies were variable and unpredictable. We
suggest that the practice of vertebroplasty using CaP should
be reconsidered.
Introduction Recently, CaP, an osteoconductive filler ma-
terial, has been used in the treatment of osteoporotic
compression fractures. However, the clinical results of
CaP-cement-augmented vertebrae are still not well estab-
lished. The purpose of this study is to assess the clinical
results of vertebroplasty with CaP by evaluating the
morphological changes of CaP cement in compressed
vertebral bodies.
Methods Fourteen patients have been followed for more
than 2 years after vertebroplasty. The following parameters
were reviewed: age, sex, T score, compliance with
osteoporosis medications, visual analog scale score, com-
pression ratio, subsequent compression fractures, and any
morphological changes in the filler material.
Results The morphological changes of injected CaP included
reabsorption, condensation, bone formation (osteogenesis),
fracture of the CaP solid hump, and heterotopic ossification.
Out of 14 patients, 11 (78.6%) developed progression of the
compression of the CaP-augmented vertebral bodies after
vertebroplasty.
Conclusions The morphological changes of the injected
CaP cement in the vertebral bodies were variable and
unpredictable. The compression of the CaP-augmented
vertebrae progressed continuously for 2 years or more.
The findings of this study suggest that vertebroplasty using
CaP cement should be reconsidered.
Keywords Calciumphosphate.Osteoporosis.
Spinalfracture.Vertebroplasty
Introduction
Percutaneous vertebroplasty (PVP) is a common and popular
procedure in osteoporotic vertebral compression fractures [1–
4]. Traditionally, polymethylmethacrylate (PMMA) cement
has been used in vertebroplasty as a filler material. However,
PMMA cement has several disadvantages, such as the
possibility of exothermal injury, lack of osteoconductivity,
and the alteration of normal biomechanics [5–8]. Therefore,
calcium phosphate (CaP), an osteoconductive filler material,
has been used in the treatment of osteoporotic compression
fractures instead of PMMA [9–11]. It has been reported that
there are advantages to the use of calcium phosphate cement
[12–15]. CaP cement has osteoconductivity and might not
alter the normal spinal biomechanics. However, the clinical
results of CaP-cement-augmented vertebrae are still not well
established. The fact that CaP has a weaker strength than
PMMA may also be a disadvantage [16]. The clinical and
radiological results of vertebroplasty using CaP cement have
rarely been reported, and there are some controversies about
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authors analyzed the radiological and clinical results of
vertebroplasty using CaP cement. The purpose of this study
is to assess the clinical validity of vertebroplasty with CaP by
evaluating the morphological changes of the CaP cement in
compressed vertebral bodies.
Clinical materials and methods
The authors performed 96 vertebroplasty or kyphoplasty
procedures in osteoporotic vertebral compression fracture
patients from December 2005 to November 2006. Among
them, 45 levels of 44 patients were treated by vertebro-
plasty with CaP cement. We included only the patients who
were followed for more than 2 years. A total of 14 levels in
14 patients were enrolled in our study. All of the patients
had a single-level osteoporotic vertebral compression
fracture. The patients with multilevel vertebral compression
fractures were excluded from this study. The patients who
were treated by kyphoplasty or who had pathologic
vertebral compression fractures from spinal metastatic
cancer, osteolytic bone tumors, and hemangioma were
excluded from this study. Also, patients who had a
secondary osteoporosis were excluded. All of the patients
participated in follow-up care via an outpatient clinic once a
month for 2 months after the PVP for the regular
administration of osteoporosis medications and postopera-
tive radiological evaluations.
Before vertebroplasty, all of the patients were evaluated
with plain X-ray films, bone mineral density scans,
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Fig. 1 Lateral plain films of a 57-year-old man with an L1
compression fracture. a Initially, the L1 vertebral body was
compressed. b Immediate postoperative lateral plain X-ray showed
well-deposited CaP cement. c Twelve months after the vertebroplasty,
recollapse and heterotopic ossification occurred (arrow), and the
injected CaP was reabsorbed. d Twenty-four months after the
vertebroplasty, the heterotopic ossification was condensed and
osteogenesis had developed in the vertebral body
Table 1 Characteristics of patients
Characteristics Value
Age (year) 69.42±10.26
Sex (M/F) 4/10
Bone mineral density
(T score)
−3.19±0.66.
Filler material
volume (mL)
3.98±0.88
Mean follow-up
period (month)
25.43±1.91
(24–30 months)
Location of compression
fracture
From T8 to L5
1 (T8); 2 (T11); 2 (T12); 4
(L1); 4 (L2); 1 (L1)
Morphological changes of
injected CaP (number of patients)
Seven of 14 patients (50%)
Reabsorption (6)
Osteogenesis (2)
Condensation (2)
Bone cement fracture (1)
Heterotopic ossification (3)
Progression of compression
of treated vertebrae
11 of 14 patients (78.6%)
2064 Osteoporos Int (2009) 20:2063–2070magnetic resonance imaging (MRI), and radionuclide bone
scanning to define the acute osteoporotic compression
fracture. The authors performed a PVP in patients who
complained of disabling back pain refractory to conserva-
tive management with analgesics and bed rest. We used a
unilateral percutaneous vertebral body access technique
through the posterolateral extrapedicular approach in all
patients. The filler material used in the vertebroplasty was
CaP cement (55% dicalcium phosphate dehydrate and 45%
tricalcium phosphate, JectOS®, Kasios, France).
Clinical and radiological analysis
We reviewed the preoperative clinical parameters such as
age, sex, bone mineral density, compliance of osteoporosis
medications, visual analog scale (VAS) score, neurologic
symptoms, and filler material (CaP cement) volume. The
VAS score was checked preoperatively, immediately post-
operatively, and postoperatively at 6, 12, and 24 months or
more (the final follow-up period). We compared the
preoperative VAS scores with the postoperative scores.
In addition, we also reviewed many radiological param-
eters such as the compression ratio, kyphotic angle,
morphological changes of the injected CaP cement in the
vertebral bodies, and the incidence of any subsequent
adjacent or remote vertebral compression fractures.
All of the patients underwent serial follow-up plain
radiographs immediately after the vertebroplasty, and
postoperatively at 6, 12, and 24 months or more (the final
follow-up period). We analyzed the morphological changes
of the injected CaP cement in the vertebral bodies in the
serial follow-up plain X-ray films.
The anterior and posterior heights ofthe fractured vertebral
bodywere assessed inorder tocalculate the compression ratio
(anterior/posterior (AP) height) before and after the vertebro-
plasty. All of the heights were measured using the Picture
Archiving and Communication System and its computer
software (PiviewSTAR™ 5.0, INFINITT, Seoul, Korea).
The degree of compression progression of the cemented
vertebral bodies, which is the compression ratio difference
between the immediate postvertebroplasty measurement and
the follow-up period measurements (12 months and the final
follow-up period after the vertebroplasty), was calculated for
all of the patients. The compression ratio difference between
12 months after the vertebroplasty and the final follow-up
period was calculated as well. We compared each of the
compression ratio differences.
Statistical analysis was performed using the Friedman
test, the Mann Whitney U test, and the Wilcoxon rank sum
test. P<0.05 was considered statistically significant. SPSS
13.0 for Windows (SPSS, Chicago, IL, USA) was used for
the statistical analysis.
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Fig. 2 Lateral plain films of a 69-year-old woman with an L2
compression fracture. a The initial lateral plain X-ray showed an
acute compression fracture and air cleft sign in the L2 vertebral
body. b Immediate postoperative lateral plain X-ray showed well-
deposited CaP cement. c Three months after the vertebroplasty,
recollapse and heterotopic ossification occurred (arrow)a n dt h e
injected CaP was reabsorbed. d Thirty months after the vertebro-
plasty, the heterotopic ossification was condensed and osteogenesis
had developed in the vertebral body
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The mean age of the patients was 69.42±10.26 years, and
there were ten females and four males. The treated levels
were distributed from T8 to L5: one in T8; one in T11; two
in T12; four in L1; four in L2; one in L4; and one in L5.
The mean follow-up period was 25.43±1.91 months (24–
30 months). The mean T score of the bone mineral density
was −3.19±0.66. The mean volume of the injected CaP
cement was 3.98±0.88 mL (Table 1).
Morphological changes of the injected CaP
Seven patients (50.0%) showed morphological changes of the
injected CaP cement for the follow-up period, and seven
patients (50.0%) did not. The morphological changes of the
injected CaP cement in the vertebral bodies were variable and
unpredictable.ThemorphologicalchangesoftheinjectedCaP
included reabsorption, condensation, bone formation (osteo-
genesis), fracture of the CaP solid hump, and heterotopic
ossification (Table 1,F i g s .1, 2, 3,a n d4). These phenomena
occurred in complex and serial fashions (Figs. 1, 2,a n d3).
Six patients presented with reabsorption of the CaP cement
(Figs. 1, 2, 3,a n d4). Osteogenesis in the augmented
vertebral body developed after reabsorption of the CaP and
could be detected by serial follow-up plain X-ray films
showing an increasing density of the vertebral body when
compared with the initial X-ray films (Figs. 1 and 2). Two
patients presented with osteogenesis. Condensation of the
CaP cement was seen in two cases; the diffusely injected
a a a
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Fig. 3 Radiologic studies
of an 80-year-old man with an
L1 compression fracture. a The
initial MRI showed an acute
compression fracture with osteo-
necrosis in the L1 vertebral body.
b Immediate postoperative lateral
plain X-ray showed well-
deposited CaP cement. c
Six months after the vertebro-
plasty, recollapse and heterotopic
ossification occurred. The lateral
plain X-ray (d), computed to-
mography (e)a n dM R I( f)w e r e
taken after 26 months after the
vertebroplasty. The injected CaP
was reabsorbed. Heterotopic os-
sification progressed and bone
fusion developed (arrow). A
subsequent vertebral compres-
sion fracture occurred at the L3
and L4 vertebrae
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body. Heterotopic ossification occurred in three patients
(Figs. 1, 2,a n d3). The heterotopic ossification developed
around the CaP-cement-augmented vertebral body. In one
case (Fig. 3), as a result of the heterotopic ossification, bone
fusion occurred below and above the CaP-augmented
vertebral body. This patient developed new compression
fractures at those two levels (Fig. 3). Two out of three of the
patients who developed heterotopic ossifications had osteo-
necrosis in the compressed vertebrae (Figs. 2 and 3). In one
case, an acute fracture of the CaP-cemented vertebral body
occurred, and a fracture of the solid hump of the CaP cement
was detected at the refractured vertebral body (Fig. 4).
Progression of the compression of the augmented vertebral
body
Out of 14 patients, eleven (78.6%) developed progression of
the compression of the CaP-augmented vertebral bodies after
vertebroplasty. Progression of the compression of the
cemented vertebral bodies was confirmed by serial follow-up
plain X-ray films. The mean AP ratio of the CaP-augmented
vertebrae decreased until 2 years or more postoperatively. The
immediate postoperative AP ratio was 68.65±6.71 and
decreased to 60.98±9.52 at 1 year after the vertebroplasty.
Also, the postoperative AP ratio continued to decrease to
59.03±11.19 at 2 years after the vertebroplasty (P<0.05,
Table 2). The mean ratio difference between the immediate
postoperative status and at 1 year postoperatively was 7.6±
6.8, and difference between the postoperative 1- and 2-year
measurements was 1.9±2.9 (Table 2). The mean difference
in the AP ratio of the compression of the vertebrae from the
immediate postoperative to the 1-year postoperative period
was significantly higher than from the postoperative 1 to
2 years or more (P<0.05, Table 2). The mean difference in
the AP ratio of the six vertebrae which developed reabsorp-
tion of the CaP cement was 16.84±2.57, and, in the eight
vertebrae which did not develop reabsorption, it was 4.95±
1.75 (P<0.05, Table 3). The treated vertebrae which
developed reabsorption of the CaP had a greater progression
of the compression after the vertebroplasty than the vertebrae
which did not develop reabsorption. The predisposing factor
for the progression of the compression of the vertebrae was
the reabsorption of the CaP cement.
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Fig. 4 Lateral plain films
of a 77-year-old man with an L1
compression fracture. a Imme-
diate postoperative lateral plain
X-ray. b Twelve months after
the vertebroplasty, recollapse
occurred and the injected CaP
was partially reabsorbed. c
Twenty-seven months after the
vertebroplasty, he presented
with back pain after a fall.
Lateral plain X-ray showed that
the CaP-augmented L1 vertebral
body was more compressed than
the immediately postoperative
and follow-up X-rays, and the
solid hump of the CaP cement
was fractured as well (arrow)
Table 2 Progression of compression of treated vertebrae
Immediate postvertebroplasty One year after vertebroplasty Twoyears or more after vertebroplasty
Compression ratio* 68.65±6.71 60.98±9.52 59.03±11.19
Difference of compression ratio* 7.6±6.8 1.9±2.9
*P<0.05
Osteoporos Int (2009) 20:2063–2070 2067Although we encouraged the patients to maintain their
regular osteoporosis medications, six patients were
intermittently administrated medications. Eight patients
maintained good compliance with their osteoporosis
medications after the vertebroplasty. Six (75.0%) out of
the eight patients with good compliance with their
osteoporosis medications had progression of the com-
pression of the augmented vertebrae. There was no
statistical significance.
Clinical outcomes
The mean preoperative VAS score was 8.4±0.6, and on
postoperative day1 it was 2.9±1.1. The mean VAS score was
significantly decreased postoperatively (P<0.05, Table 4).
The mean VAS scores were 2.9±1.2 at 6 months postoper-
ative, 3.1±1.3 at 12 months postoperative, and 3.0±2.4 at
the final follow-up (more than 24 months; Table 4). The
mean of the VAS scores at 6 and 12 months postoperative
was slightly higher than at day1 after the vertebroplasty.
However, there was no statistical significance (P>0.05).
Fortunately, although serial recollapses occurred after the
vertebroplasty with CaP, the mean score of the VAS of the
back remained low, and there were no neurologic symptoms.
However, in the cases of heterotopic ossifications with new
vertebral compression fractures and fracture of injected CaP
solid hump, the patients presented with high VAS scores (9
a n d8p o i n t s ) .
Discussion
PMMA was commonly used as a filler material for
vertebroplasty. However, there are complications related
with PMMA [1–4,17]. Recently, several studies have
reported concerns about subsequent vertebral compression
fractures after vertebroplasty [18–20]. Augmentation using
PMMA can alter the normal spinal biomechanics and may
result in subsequent vertebral compression fractures
[7,8,12,14,21]. In contrast, osteoconductive filler materials
such as CaP may prevent subsequent vertebral compression
fractures. CaP cement has additional advantages including
the absence of exothermic effects and osteoconductive
activity [11–13,15].
One advantage of the CaP cement is that it is less stiff
than PMMA, but this can also be seen as a disadvantage
[16]. A case of recollapse of the vertebral body after
kyphoplasty using CaP was reported [16]. In that case, an
additional extensive surgical treatment was needed for the
CaP-augmented vertebrae, which was severely collapsed
and had a compressed thecal sac. CaP may not provide
enough initial stiffness, and therefore recollapse may occur
in the CaP-augmented vertebrae. In some patients, recol-
lapse occurred 1 year after the vertebroplasty. The degree of
the progression of the compression was more severe 1 year
after the vertebroplasty than after more than a year
postoperatively. Although the degree of progression of the
compression was small after 1 year postoperatively, we
think patients need regular follow-ups for serial reviews of
plain X-rays. Furthermore, we suggest if reabsorption of the
CaP cement occurs, the CaP cement may not provide
enough stiffness to support the compressed vertebrae. Even
though reabsorption of the CaP in the vertebral body is not
a pathologic condition, it may result in the recollapse of the
cemented vertebrae. It seems likely that reabsorption of the
CaP may have adverse effects and may be a high-risk factor
for the development of recollapse after vertebroplasty.
The bioactivity of the injected CaP cannot be controlled
factitiously; therefore, the morphological changes of the
CaP in the augmented vertebrae may be unpredictable and
variable. The morphological changes of the injected CaP
included reabsorption, condensation, bone formation (oste-
ogenesis), fracture of the CaP solid hump, and heterotopic
ossification. Reabsorption, osteogenesis, and heterotopic
ossification were related with the bioactive properties of the
CaP. In contrast, condensation and fracture of the CaP
cement were related with the physical properties of the CaP.
In two cases, condensation of the CaP occurred with
Table 3 Relationship between reabsorption of CaP and recollapse of treated vertebrae
Patients with reabsorption of CaP Patients without reabsorption of CaP
Number of patient Six of 14 patients Eight of 14 patients
The mean difference of AP ratio of compressed vertebrae (P<0.05) 16.84±2.57 4.95±1.75
Table 4 The changes of VAS score of back during followed period
Period Preoperative Immediate postoperative Postoperative 6months Postoperative 12months Final followed period
VAS score 8.4±0.6 2.9±1.1* 2.9±1.2 3.1±1.3 3.0±2.4
*P<0.05
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the fact that the strength of the CaP is not sufficient to
support the compressed vertebral body. Also, the fracture of
the solid hump of the CaP cement occurred after trauma.
It is well known that the bioactivity of CaP cement is
one of its beneficial properties. However, we think that the
bioactivity of CaP may not always be beneficial. CaP may
not only have osteoconductive properties but osteoinduc-
tive properties as well [22,23]. In animal studies, it has been
reported that CaP can result in ectopic bone formation in
the muscular layers due to its osteoinductive properties
[22,23]. Similarly, we suggest that the osteoinductivity of
CaP can induce unwanted heterotopic ossifications in
humans. In our study, heterotopic ossifications developed
in three patients after vertebroplasty, and, in one case,
heterotopic ossification resulted in bony fusions (Fig. 3).
We suggest that bony fusion after heterotopic ossification
may alter the normal biomechanics. In our study, subse-
quent vertebral compression fractures occurred in the
patient with bony fusions after heterotopic ossification
developed (Fig. 3). Furthermore, the mass of the hetero-
topic ossification may compress any adjacent structures.
Fortunately, our cases did not present symptoms related
with the compression of any adjacent structures. Although
we cannot reveal the exact pathogenesis of the heterotopic
ossification in vertebroplasty with CaP, we suggest that any
CaP cement leakage into the adjacent tissue area is one
possible cause of the heterotopic ossification. Although
leakage of the CaP did not occur grossly during the
vertebroplasty, we suggest that micro-leakage of the CaP
might have occurred after the vertebroplasty via puncture,
fracture, or osteonecrosis sites of the vertebral body and
may have induced the heterotopic ossification. In our
opinion, the leakage of CaP cement should be prevented
during vertebroplasty, and CaP should not be used in
patients with vertebral osteonecrosis.
We do not know the strength of the vertebrae that
underwent osteogenesis after the injection of CaP. The
osteoconductive effect of the CaP cement augmentation
on the biomechanics is uncertain. The strength of the
CaP-augmented vertebrae which developed osteogenesis
after the vertebroplasty might be stronger than the
normal vertebrae and therefore may alter the normal
biomechanics. Thus, we think that the bioactivity of CaP
m a yr e s u l ti nn ob e t t e ro fa ne n dp o i n tt h a nP M M A
biomechanically.
The morphological changes of the augmented CaP have
progressed not simply but in complex and serial fashions.
The authors suggest that the injected CaP will be able to
change for a long time due to its bioactivity, and patients
who were treated with CaP need a long-term follow-up and
regular serial X-ray film screening. We do not yet know the
final changes of the injected cement.
In this study, we were only able to follow up and assess
14 patients. Therefore, the results of our study cannot be
generalized to all the CaP cements. For the clinical and
radiologic outcomes to be better established, more patients
should be studied and the follow-up period should be
required.
Conclusions
The morphological changes of the injected CaP cement in
the vertebral bodies were variable and unpredictable and
included reabsorption, condensation, bone formation (oste-
ogenesis), fracture of the CaP solid hump, and heterotopic
ossification. These phenomena occurred in complex and
serial fashions. The compression of the CaP-augmented
vertebrae progressed continuously for 2 years or longer.
The findings of this study suggest that the practice of
performing vertebroplasty using CaP cement should be
reconsidered. Additionally, we believe that the strength of
the CaP cement may be too weak for vertebroplasty;
bioactivity may not be necessary for filler materials, and
new ideal filler materials should be developed.
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